Phase I/II Study of EGFR CART Cells for Patients With Metastatic Colorectal Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Anti-EGFR CAR-transduced T cells (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 24 May 2017 New trial record
- 23 May 2017 Status changed from not yet recruiting to recruiting.